Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Advanced Liver Disease”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Not applicableNot Yet RecruitingNCT07777198
What this trial is testing

Liver Stiffness Changes by iLivTouch to Predict Liver-Related Events in MAFLD

Who this might be right for
MAFLD
Beijing Friendship Hospital 2,303
Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT02010255
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Who this might be right for
Chronic HCV Infection
Gilead Sciences 334
Not applicableLooking for participantsNCT07042308
What this trial is testing

Natural History of Advanced Chronic Liver Diseases

Who this might be right for
CirrhosisAdvanced Chronic Liver Disease
Chinese University of Hong Kong 500
Not applicableUnknownNCT06147947
What this trial is testing

Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD

Who this might be right for
Liver CirrhosisLiver FibrosisPortal Hypertension
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Testing effectiveness (Phase 2)UnknownNCT05542615
What this trial is testing

Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).

Who this might be right for
Liver CirrhosisHepatitis C, ChronicEpigenetic Disorder
University of Guadalajara 60
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Not applicableWithdrawnNCT05050721
What this trial is testing

Natural History of Non Alcoholic Fatty Liver Disease and Predictors of Advanced Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Methodist Health System
Large-scale testing (Phase 3)WithdrawnNCT02837939
What this trial is testing

Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction

Who this might be right for
CirrhosisLiver Failure
Martin Janičko
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableUnknownNCT02865369
What this trial is testing

Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment

Who this might be right for
Chronic Hepatitis C
Sang Gyune Kim 103
Large-scale testing (Phase 3)Study completedNCT03883698
What this trial is testing

Safety of Sofosbuvir in People With Advanced Kidney Failure

Who this might be right for
Kidney Failure, ChronicHepatitis C
Sanjay Gandhi Postgraduate Institute of Medical Sciences 30
Not applicableUnknownNCT04615091
What this trial is testing

Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery

Who this might be right for
Advanced Chronic Liver DiseaseSurgery--Complications
Azienda Ospedaliera Universitaria Integrata Verona 250
Not applicableStudy completedNCT07721454
What this trial is testing

AI-ACLD Study: Artificial Intelligence in Advanced Chronic Liver Disease

Who this might be right for
Advance Chronic Liver Disease (ACLD)
Antonio Galante 8
Not applicableStudy completedNCT04455464
What this trial is testing

Effect of Midodrine on HVPG in Advanced Chronic Liver Disease

Who this might be right for
Chronic Liver Disease
Institute of Liver and Biliary Sciences, India 60
Not applicableStudy completedNCT05044663
What this trial is testing

Liver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in MASLD Related Compensated Advanced Chronic Liver Disease.

Who this might be right for
Chronic Liver Disease
Institute of Liver and Biliary Sciences, India 325
Early research (Phase 1)Study completedNCT00082823
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Not applicableStudy completedNCT06181474
What this trial is testing

MELD ESAS Evolution: Assessment of the Symptomatic Burden of Patients With Advanced Chronic Liver Disease

Who this might be right for
Palliative CareEnd Stage Liver DIsease
Unidade Local de Saúde de Matosinhos, EPE 44
Post-approval studies (Phase 4)WithdrawnNCT03143998
What this trial is testing

Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC
Next Page